Genomic studies are now approaching "industrial" speed and scale, thanks to advances in gene sequencing and the increasing availability of high-throughput methods for studying genes, the proteins they encode, and the pathways in which they are involved. Data can now be acquired on many genes at once, either sequentially or in parallel.
It is also possible to expand the range of genomic effects being examined. The abundance of new data available means that more targets should now be identifiable, but the key to finding such new targets will be to use the right combination of technologies and have them ideally integrated.
This report reviews leading companies and their high-throughput technologies in the following areas: gene sequencing, genotyping, gene expression monitoring, gene functional studies, proteomics, and genomic target identification and validation.
The report includes direct quotes and extensive commentaries from more than a dozen leading experts in this field. Over 20 companies' specific approaches are discussed in detail, and more than 50 technologies overall are covered. The report identifies the leaders in this field, outlines the business and scientific issues shaping the evolution of high-throughput genomics, and discusses the commercial outlook for this field.
View Cart
